FDA Warns 30 Telehealth Companies Over Weight-Loss Drug Ads
The FDA has sent warning letters to 30 telehealth companies this week, saying their marketing for compounded weight-loss drugs…
-
-
Foundayo GLP-1 Pill by Eli Lilly Launches via Telehealth in US
Eli Lilly is shaking up the weight loss world by making their newest treatment, Foundayo, easier to get than…
-
Novo Nordisk Launches Wegovy Subscription Program Ahead of Anticipated Oral GLP-1 Competition
Novo Nordisk recently launched a pioneering multimonth subscription program for its semaglutide obesity medication. This initiative offers a fixed…
-
Telehealth Platforms Expand Access to GLP-1 Weight Loss Medications Through Digital Care Models
The way we approach metabolic health has undergone a massive shift recently, largely driven by the explosion of interest…
